Sun Pharmaceutical Industries Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 5,881.30 | 4,986.81 | 5,867.67 |
| Operating Expense | 3,808.45 | 3,594.91 | 4,187.87 |
| Net Profit | 1,115.14 | 608.70 | 705.44 |
| Net Profit Margin | 18.96% | 12.21% | 12.02% |
| Earning Per Share | 4.60 | 2.50 | 2.90 |
| EBIDTA | 2,072.85 | 1,391.90 | 1,679.80 |
| Effective Tax Rate | 17.91% | 17.26% | 23.32% |
Particulars
Jun 2026
Revenue5,881.30
Operating Expense3,808.45
Net Profit1,115.14
Net Profit Margin18.96
Earning Per Share4.60
EBIDTA2,072.85
Effective Tax Rate17.91
